 | • レポートコード：MRC2-11QY11639 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は診断バイオマーカーのグローバル市場について調査・分析したレポートです。種類別（S100、MART-1、Gp100、HMB45、AFP、BCR-ABL、その他）市場規模、用途別（病院、がん研究所、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別診断バイオマーカーの競争状況、市場シェア ・世界の診断バイオマーカー市場：種類別市場規模 2015年-2020年（S100、MART-1、Gp100、HMB45、AFP、BCR-ABL、その他） ・世界の診断バイオマーカー市場：種類別市場規模予測 2021年-2026年（S100、MART-1、Gp100、HMB45、AFP、BCR-ABL、その他） ・世界の診断バイオマーカー市場：用途別市場規模 2015年-2020年（病院、がん研究所、診断研究所） ・世界の診断バイオマーカー市場：用途別市場規模予測 2021年-2026年（病院、がん研究所、診断研究所） ・北米の診断バイオマーカー市場分析：米国、カナダ ・ヨーロッパの診断バイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの診断バイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の診断バイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの診断バイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biocrates Life Sciences、Augurex Life Sciences、Biomedical、Target Discovery、Banyan Biomarkers、Astute Medical、Axela ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.
Revenue growth in the diagnostic biomarker is expected to gain traction in the near future as they are dependent on the prevalence of diseases such as cancer and other cardiac problems. Significant growth the sector of molecular biology and advancements in various laboratory techniques is expected to support the diagnostic biomarker market over the forecast period. The advancement in the technology and rise in adoption rate of the biomarkers in diagnosis has expanded the feasibility of the use of biomarkers in diagnosis of various disorders such as genetic, cardiac, cancer and other immunological diseases. Also, for clinical investigators the biomarkers can be a dynamic and powerful tool to analyze the spectrum of neurological disease.
Market Analysis and Insights: Global Diagnostic Biomarker Market
The global Diagnostic Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Diagnostic Biomarker Scope and Market Size
Diagnostic Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Biocrates Life Sciences
Augurex Life Sciences
Biomedical
Target Discovery
Banyan Biomarkers
Astute Medical
Axela
…
Market segment by Type, the product can be split into
S100
MART-1
Gp100
HMB45
AFP
BCR-ABL
Others
Market segment by Application, split into
Hospitals
Cancer Research Institutes
Diagnostic Labs
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diagnostic Biomarker Revenue
1.4 Market by Type
1.4.1 Global Diagnostic Biomarker Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 S100
1.4.3 MART-1
1.4.4 Gp100
1.4.5 HMB45
1.4.6 AFP
1.4.7 BCR-ABL
1.4.8 Others
1.5 Market by Application
1.5.1 Global Diagnostic Biomarker Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Research Institutes
1.5.4 Diagnostic Labs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Biomarker Market Perspective (2015-2026)
2.2 Global Diagnostic Biomarker Growth Trends by Regions
2.2.1 Diagnostic Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diagnostic Biomarker Historic Market Share by Regions (2015-2020)
2.2.3 Diagnostic Biomarker Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diagnostic Biomarker Market Growth Strategy
2.3.6 Primary Interviews with Key Diagnostic Biomarker Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Biomarker Players by Market Size
3.1.1 Global Top Diagnostic Biomarker Players by Revenue (2015-2020)
3.1.2 Global Diagnostic Biomarker Revenue Market Share by Players (2015-2020)
3.1.3 Global Diagnostic Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diagnostic Biomarker Market Concentration Ratio
3.2.1 Global Diagnostic Biomarker Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarker Revenue in 2019
3.3 Diagnostic Biomarker Key Players Head office and Area Served
3.4 Key Players Diagnostic Biomarker Product Solution and Service
3.5 Date of Enter into Diagnostic Biomarker Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diagnostic Biomarker Historic Market Size by Type (2015-2020)
4.2 Global Diagnostic Biomarker Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diagnostic Biomarker Market Size by Application (2015-2020)
5.2 Global Diagnostic Biomarker Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diagnostic Biomarker Market Size (2015-2020)
6.2 Diagnostic Biomarker Key Players in North America (2019-2020)
6.3 North America Diagnostic Biomarker Market Size by Type (2015-2020)
6.4 North America Diagnostic Biomarker Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diagnostic Biomarker Market Size (2015-2020)
7.2 Diagnostic Biomarker Key Players in Europe (2019-2020)
7.3 Europe Diagnostic Biomarker Market Size by Type (2015-2020)
7.4 Europe Diagnostic Biomarker Market Size by Application (2015-2020)
8 China
8.1 China Diagnostic Biomarker Market Size (2015-2020)
8.2 Diagnostic Biomarker Key Players in China (2019-2020)
8.3 China Diagnostic Biomarker Market Size by Type (2015-2020)
8.4 China Diagnostic Biomarker Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diagnostic Biomarker Market Size (2015-2020)
9.2 Diagnostic Biomarker Key Players in Japan (2019-2020)
9.3 Japan Diagnostic Biomarker Market Size by Type (2015-2020)
9.4 Japan Diagnostic Biomarker Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diagnostic Biomarker Market Size (2015-2020)
10.2 Diagnostic Biomarker Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diagnostic Biomarker Market Size by Type (2015-2020)
10.4 Southeast Asia Diagnostic Biomarker Market Size by Application (2015-2020)
11 India
11.1 India Diagnostic Biomarker Market Size (2015-2020)
11.2 Diagnostic Biomarker Key Players in India (2019-2020)
11.3 India Diagnostic Biomarker Market Size by Type (2015-2020)
11.4 India Diagnostic Biomarker Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diagnostic Biomarker Market Size (2015-2020)
12.2 Diagnostic Biomarker Key Players in Central & South America (2019-2020)
12.3 Central & South America Diagnostic Biomarker Market Size by Type (2015-2020)
12.4 Central & South America Diagnostic Biomarker Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Biocrates Life Sciences
13.1.1 Biocrates Life Sciences Company Details
13.1.2 Biocrates Life Sciences Business Overview
13.1.3 Biocrates Life Sciences Diagnostic Biomarker Introduction
13.1.4 Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2015-2020))
13.1.5 Biocrates Life Sciences Recent Development
13.2 Augurex Life Sciences
13.2.1 Augurex Life Sciences Company Details
13.2.2 Augurex Life Sciences Business Overview
13.2.3 Augurex Life Sciences Diagnostic Biomarker Introduction
13.2.4 Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2015-2020)
13.2.5 Augurex Life Sciences Recent Development
13.3 Biomedical
13.3.1 Biomedical Company Details
13.3.2 Biomedical Business Overview
13.3.3 Biomedical Diagnostic Biomarker Introduction
13.3.4 Biomedical Revenue in Diagnostic Biomarker Business (2015-2020)
13.3.5 Biomedical Recent Development
13.4 Target Discovery
13.4.1 Target Discovery Company Details
13.4.2 Target Discovery Business Overview
13.4.3 Target Discovery Diagnostic Biomarker Introduction
13.4.4 Target Discovery Revenue in Diagnostic Biomarker Business (2015-2020)
13.4.5 Target Discovery Recent Development
13.5 Banyan Biomarkers
13.5.1 Banyan Biomarkers Company Details
13.5.2 Banyan Biomarkers Business Overview
13.5.3 Banyan Biomarkers Diagnostic Biomarker Introduction
13.5.4 Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2015-2020)
13.5.5 Banyan Biomarkers Recent Development
13.6 Astute Medical
13.6.1 Astute Medical Company Details
13.6.2 Astute Medical Business Overview
13.6.3 Astute Medical Diagnostic Biomarker Introduction
13.6.4 Astute Medical Revenue in Diagnostic Biomarker Business (2015-2020)
13.6.5 Astute Medical Recent Development
13.7 Axela
13.7.1 Axela Company Details
13.7.2 Axela Business Overview
13.7.3 Axela Diagnostic Biomarker Introduction
13.7.4 Axela Revenue in Diagnostic Biomarker Business (2015-2020)
13.7.5 Axela Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diagnostic Biomarker Key Market Segments
Table 2. Key Players Covered: Ranking by Diagnostic Biomarker Revenue
Table 3. Ranking of Global Top Diagnostic Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diagnostic Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of S100
Table 6. Key Players of MART-1
Table 7. Key Players of Gp100
Table 8. Key Players of HMB45
Table 9. Key Players of AFP
Table 10. Key Players of BCR-ABL
Table 11. Key Players of Others
Table 12. Global Diagnostic Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Diagnostic Biomarker Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Diagnostic Biomarker Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Diagnostic Biomarker Market Share by Regions (2015-2020)
Table 16. Global Diagnostic Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Diagnostic Biomarker Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Diagnostic Biomarker Market Growth Strategy
Table 22. Main Points Interviewed from Key Diagnostic Biomarker Players
Table 23. Global Diagnostic Biomarker Revenue by Players (2015-2020) (Million US$)
Table 24. Global Diagnostic Biomarker Market Share by Players (2015-2020)
Table 25. Global Top Diagnostic Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Biomarker as of 2019)
Table 26. Global Diagnostic Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Diagnostic Biomarker Product Solution and Service
Table 29. Date of Enter into Diagnostic Biomarker Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Diagnostic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 32. Global Diagnostic Biomarker Market Size Share by Type (2015-2020)
Table 33. Global Diagnostic Biomarker Revenue Market Share by Type (2021-2026)
Table 34. Global Diagnostic Biomarker Market Size Share by Application (2015-2020)
Table 35. Global Diagnostic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 36. Global Diagnostic Biomarker Market Size Share by Application (2021-2026)
Table 37. North America Key Players Diagnostic Biomarker Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Diagnostic Biomarker Market Share (2019-2020)
Table 39. North America Diagnostic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 40. North America Diagnostic Biomarker Market Share by Type (2015-2020)
Table 41. North America Diagnostic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 42. North America Diagnostic Biomarker Market Share by Application (2015-2020)
Table 43. Europe Key Players Diagnostic Biomarker Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Diagnostic Biomarker Market Share (2019-2020)
Table 45. Europe Diagnostic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Diagnostic Biomarker Market Share by Type (2015-2020)
Table 47. Europe Diagnostic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Diagnostic Biomarker Market Share by Application (2015-2020)
Table 49. China Key Players Diagnostic Biomarker Revenue (2019-2020) (Million US$)
Table 50. China Key Players Diagnostic Biomarker Market Share (2019-2020)
Table 51. China Diagnostic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 52. China Diagnostic Biomarker Market Share by Type (2015-2020)
Table 53. China Diagnostic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 54. China Diagnostic Biomarker Market Share by Application (2015-2020)
Table 55. Japan Key Players Diagnostic Biomarker Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Diagnostic Biomarker Market Share (2019-2020)
Table 57. Japan Diagnostic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Diagnostic Biomarker Market Share by Type (2015-2020)
Table 59. Japan Diagnostic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Diagnostic Biomarker Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Diagnostic Biomarker Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Diagnostic Biomarker Market Share (2019-2020)
Table 63. Southeast Asia Diagnostic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Diagnostic Biomarker Market Share by Type (2015-2020)
Table 65. Southeast Asia Diagnostic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Diagnostic Biomarker Market Share by Application (2015-2020)
Table 67. India Key Players Diagnostic Biomarker Revenue (2019-2020) (Million US$)
Table 68. India Key Players Diagnostic Biomarker Market Share (2019-2020)
Table 69. India Diagnostic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 70. India Diagnostic Biomarker Market Share by Type (2015-2020)
Table 71. India Diagnostic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 72. India Diagnostic Biomarker Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Diagnostic Biomarker Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Diagnostic Biomarker Market Share (2019-2020)
Table 75. Central & South America Diagnostic Biomarker Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Diagnostic Biomarker Market Share by Type (2015-2020)
Table 77. Central & South America Diagnostic Biomarker Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Diagnostic Biomarker Market Share by Application (2015-2020)
Table 79. Biocrates Life Sciences Company Details
Table 80. Biocrates Life Sciences Business Overview
Table 81. Biocrates Life Sciences Product
Table 82. Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2015-2020) (Million US$)
Table 83. Biocrates Life Sciences Recent Development
Table 84. Augurex Life Sciences Company Details
Table 85. Augurex Life Sciences Business Overview
Table 86. Augurex Life Sciences Product
Table 87. Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2015-2020) (Million US$)
Table 88. Augurex Life Sciences Recent Development
Table 89. Biomedical Company Details
Table 90. Biomedical Business Overview
Table 91. Biomedical Product
Table 92. Biomedical Revenue in Diagnostic Biomarker Business (2015-2020) (Million US$)
Table 93. Biomedical Recent Development
Table 94. Target Discovery Company Details
Table 95. Target Discovery Business Overview
Table 96. Target Discovery Product
Table 97. Target Discovery Revenue in Diagnostic Biomarker Business (2015-2020) (Million US$)
Table 98. Target Discovery Recent Development
Table 99. Banyan Biomarkers Company Details
Table 100. Banyan Biomarkers Business Overview
Table 101. Banyan Biomarkers Product
Table 102. Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2015-2020) (Million US$)
Table 103. Banyan Biomarkers Recent Development
Table 104. Astute Medical Company Details
Table 105. Astute Medical Business Overview
Table 106. Astute Medical Product
Table 107. Astute Medical Revenue in Diagnostic Biomarker Business (2015-2020) (Million US$)
Table 108. Astute Medical Recent Development
Table 109. Axela Company Details
Table 110. Axela Business Overview
Table 111. Axela Product
Table 112. Axela Revenue in Diagnostic Biomarker Business (2015-2020) (Million US$)
Table 113. Axela Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Biomarker Market Share by Type: 2020 VS 2026
Figure 2. S100 Features
Figure 3. MART-1 Features
Figure 4. Gp100 Features
Figure 5. HMB45 Features
Figure 6. AFP Features
Figure 7. BCR-ABL Features
Figure 8. Others Features
Figure 9. Global Diagnostic Biomarker Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Cancer Research Institutes Case Studies
Figure 12. Diagnostic Labs Case Studies
Figure 13. Diagnostic Biomarker Report Years Considered
Figure 14. Global Diagnostic Biomarker Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Diagnostic Biomarker Market Share by Regions: 2020 VS 2026
Figure 16. Global Diagnostic Biomarker Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Diagnostic Biomarker Market Share by Players in 2019
Figure 19. Global Top Diagnostic Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Biomarker as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Diagnostic Biomarker Revenue in 2019
Figure 21. North America Diagnostic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Diagnostic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Diagnostic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Diagnostic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Diagnostic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Diagnostic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Diagnostic Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
膵臓がん診断の世界市場（～2026年） Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Bio…- 肺がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lung Cancer Diagnostic Tests Scope and Market Size Lung C…
- 前立腺がんバイオマーカーの世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. Market Analysis and Insights: Global Prostate Cancer Biomarker Market The gl…
- ボーカルバイオマーカーの世界市場（～2026年） Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known…
- ゲノムバイオマーカーの世界市場（～2026年） A measurable DNA and/or RNA characteristic that is an indicator of normal biologic processes, pathogenic processes, and/or response to therapeutic or other interventions. Major factors contributing to the growth of the global genomic biomarker market include increasing prevalence of chronic diseases…